SonoScape Medical Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Kunxiang Wu

Geschäftsführender

CN¥900.0k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	no data
Eigentum des Geschäftsführers	n/a
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	keine Daten

Jüngste Management Updates

Recent updates

Geschäftsführer

Kunxiang Wu (61 yo)

no data

Amtszeit

CN¥900,000

Vergütung

Mr. Kunxiang Wu is General Manager & Director of SonoScape Medical Corp.

SonoScape Medical Management

Management Kriterienprüfungen 1/4

Wichtige Informationen

Jüngste Management Updates

SonoScape Medical Corp., Annual General Meeting, May 10, 2024

SonoScape Medical Corp., Annual General Meeting, May 10, 2024

Less than half of directors are independent

SonoScape Medical Corp. Approves Board Elections

Insufficient new directors

SonoScape Medical Corp. Announces Executive Election

Recent updates

Dividend increased to CN¥0.32

SonoScape Medical Corp. 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 29 May 2024

First quarter 2024 earnings released: EPS: CN¥0.23 (vs CN¥0.32 in 1Q 2023)

Full year 2023 earnings released: EPS: CN¥1.06 (vs CN¥0.86 in FY 2022)

SonoScape Medical Corp., Annual General Meeting, May 10, 2024

SonoScape Medical Corp., Annual General Meeting, May 10, 2024

SonoScape Medical Corp. to Report Q1, 2024 Results on Apr 27, 2024

Less than half of directors are independent

Investor sentiment improves as stock rises 17%

SonoScape Medical Corp. Approves Board Elections

SonoScape Medical Corp. to Report Fiscal Year 2023 Results on Apr 12, 2024

Now 21% undervalued

SonoScape Medical Corp. (SZSE:300633) announces an Equity Buyback for CNY 120 million worth of its shares.

SonoScape Medical Corp. (SZSE:300633) announces an Equity Buyback for CNY 120 million worth of its shares.

Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.17 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.32 (vs CN¥0.29 in 2Q 2022)

SonoScape Medical Corp. to Report Q2, 2023 Results on Aug 23, 2023

SonoScape Medical Corp. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2023

Full year 2022 earnings released: EPS: CN¥0.86 (vs CN¥0.62 in FY 2021)

Investor sentiment improved over the past week

Insufficient new directors

Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.076 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.18 in 2Q 2021)

Investor sentiment improved over the past week

Sonoscape Medical Corp. Announces Final Dividend on Share A for 2021, Payable on July 15, 2022

SonoScape Medical Corp. Approves 2021 Profit Distribution Plan

SonoScape Medical Corp. Proposes Final Cash Dividend for 2021

First quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.09 in 1Q 2021)

SonoScape S-Fetus 4.0 Release to Simplify Sonography Process

SonoScape Medical Corp. Receives FDA 510(k) Clearance for HD-550 Endoscopy system

Third quarter 2021 earnings released: EPS CN¥0.076 (vs CN¥0.004 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.085 in 2Q 2020)

SonoScape Obtains CE-Mark for Its Linear Array Echoendoscope EG-UC5T

Sonoscape Medical Corp. Proposes Final Cash Dividend for 2020

First quarter 2021 earnings released: EPS CN¥0.09 (vs CN¥0.02 loss in 1Q 2020)

New 90-day low: CN¥20.36

SonoScape Medical Corp. Announces Executive Election

New 90-day low: CN¥21.50

New 90-day low: CN¥24.31

Third quarter earnings released

SonoScape Medical Corp. announced that it expects to receive CNY 1.2 billion in funding

New 90-day low: CN¥27.25

Earnings released

New 90-day low - CN¥30.72

SonoScape Medical Corp. to Report First Half, 2020 Results on Aug 26, 2020

Geschäftsführer

Amtszeit

Vergütung